Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019003062) TAMPER-PROOF DOSAGE FORM COMPRISING PHARMACEUTICALLY ACTIVE AGENT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/003062 International Application No.: PCT/IB2018/054579
Publication Date: 03.01.2019 International Filing Date: 21.06.2018
IPC:
A61K 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
ZENVISION PHARMA LLP [IN/IN]; First Floor, K. K. Chambers, SIR P. T. Road Fort, Maharashtra, Mumbai 400001, IN
Inventors:
BOBBA, Sivakumar, Venkata; IN
JADHAV, Bhimrao; IN
SHINDE, Dhananjay; IN
Agent:
MAJUMDAR, Subhatosh; IN
GANGULI, Dr., Sanchita; IN
SEN, Abhishek; IN
VENKATESH, Mythili; IN
MAJUMDAR, Amrita; IN
KUNDU, Subarna; IN
CHAUBEY, Priyanka; IN
Priority Data:
20172102279729.06.2017IN
Title (EN) TAMPER-PROOF DOSAGE FORM COMPRISING PHARMACEUTICALLY ACTIVE AGENT
(FR) FORME GALÉNIQUE INVIOLABLE COMPRENANT UN AGENT PHARMACEUTIQUEMENT ACTIF
Abstract:
(EN) The present disclosure relates to tamper-proof dosage form comprising oncological pharmaceutically active agent or other active ingredient which is susceptible to topical or nasal contact. The tamper-proof dosage form according to present invention resist crushing, cutting or chewing and prevents topical and inhalational contact of active ingredient which leads to no adverse clinical symptom.
(FR) La présente invention concerne une forme galénique inviolable comprenant un agent pharmaceutiquement actif oncologique ou un autre principe actif qui est sensible à un contact topique ou nasal. La forme galénique inviolable selon la présente invention résiste à l'écrasement, à la coupe ou à la mastication et empêche le contact topique et par inhalation du principe actif ce qui conduit à une absence de symptôme clinique indésirable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)